K971039

Substantially Equivalent

HEMAGEN ANTI CARDIOLIPIN SCREEN

Applicant: Hemagen Diagnostics, Inc.
Product code: MID
Advisory panel: Immunology
Date received: 1997-03-21
Decision date: 1997-06-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Waltham, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.